OLYSIO (Janssen Products LP)
Welcome to the PulseAid listing for the OLYSIO drug offered from Janssen Products LP. This Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],HCV NS3/4A Protease Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Products LP |
NON-PROPRIETARY NAME: | simeprevir |
SUBSTANCE NAME: | SIMEPREVIR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],HCV NS3/4A Protease Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-11-22 |
END MARKETING DATE: | 0000-00-00 |
OLYSIO HUMAN PRESCRIPTION DRUG Details:
Item Description | OLYSIO from Janssen Products LP |
LABELER NAME: | Janssen Products LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2013-11-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59676-225_03cb3b41-7b64-4266-9f82-83cb4550426a |
PRODUCT NDC: | 59676-225 |
APPLICATION NUMBER: | NDA205123 |
Other SIMEPREVIR Pharmaceutical Manufacturers / Labelers: